Adaptive Biotechnologies' Grant

Adaptive Biotechnologies raised a round of funding on November 19, 2010. Investors include Qualifying Therapeutic Discovery Project.

Adaptive Biotechnologies, formerly Adaptive TCR, is a pioneer in immunosequencing diagnostics, with a focus in oncology. The Company leverages advances in next generation sequencing ("NGS") to profile…

Articles about Adaptive Biotechnologies' Grant: